✦ LIBER ✦

609 Predicting response and anaemia in HCV genotype 1 patients treated with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®): A generalised additive logistic model (GAM) analysis

✍ Scribed by E. Snoeck; J.R. Wade; M. Lamb; E. Duff; K. Jorga

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[658] OPTIMAL PRE-TREATMENT HCV-RNA LEVE

✍ S. Zeuzem; M.W. Fried; F. Torriani; E. Zehnter; T. Berg; A. Lin; S.J. Hadziyanni 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 128 KB

O.161 High SVR rates with 24 weeks of pe

✍ P. Ferenci; T. Scherzer; H. Laferl; K. Staufer; A. Maieron; M. Gschwantler; H. B 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 140 KB

P.411 The impact of age on sustained vir

✍ J. Rockstroh; F.J. Torriani; M. Rodriguez Torres; E. Lissen; A. Lazzarin; J. De 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 274 KB

522 Combination therapy with peginterfer

✍ O. Weiland; M.W. Fried; S.J. Hadziyannis; G.R. Foster; D. Messinger; K. Freivoge 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB

O.160 16 or 24 weeks of peginterferon al

✍ S. Zeuzem; S. Pappas; L. Nyberg; S. Greenbloom; A. Gibas; B. Bacon; E. Godofsky; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 143 KB

[613] VIROLOGICAL RESPONSE AT 4 AND 12 W

✍ P. Marcellin; S.J. Hadziyannis; T. Berg; J.M. Sanchez-Tapias; J.-P. Bronowicki; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 259 KB